← Back to archive

Sunday, March 1, 2026

FDA trades monkeys for machines

Hey builders, today brings us more news in AI. The FDA is ditching monkeys for AI models and human organoids in drug testing (bold move), while Switzerland just dropped a fully open AI model with completely transparent training data and architecture—no black boxes here. Meanwhile, chatbot interviewers are quietly taking over hiring screens across the industry. Would you trust an AI to decide if you're worth hiring?

FDA trades monkeys for machines

Top Stories

1
FDA Pushes for Fewer Monkeys and More Machines

The FDA is replacing animal testing requirements with AI computational models, human organoids, and real-world data to accelerate drug development, improve safety predictions, and reduce costs. This paradigm shift in drug evaluation begins immediately and could eventually spare thousands of laboratory animals while delivering treatments to patients faster.

regulationaidrug-developmenthealthcare
2
Chatbot Interviewers Fill More Jobs

Article content unavailable due to security verification blocking access; title suggests research on AI chatbot adoption in recruitment and hiring processes.

chatbotshr-techrecruitmententerprise-ai-adoption
3
Switzerland Releases 100% Open AI Model

artificialintelligence-news.com

Switzerland releases Apertus, a fully transparent open-source AI model (8B and 70B parameters) trained on 15 trillion tokens in 1,000+ languages, with complete public access to training data, weights, and architecture. The initiative positions AI as public infrastructure while demonstrating that powerful generative models can maintain full openness and regulatory compliance.

open-sourcellmmultilingualtransparency
4
Agent Infra Standardization and Protocols

Twitter

A highly-viewed Twitter post from Zed announcing a user-requested feature related to agent infrastructure standardization, though the full technical details are not included in the provided content.

agentsdeveloper-toolsinfrastructure

Keep Reading

Industry Voices

Enjoyed this issue?

Get daily AI intel delivered to your inbox. No fluff, just the stories that matter.